RAINBOW Rainbow Childrens Medicare Q1 FY27 results (Apr–Jun 2026) and concall
Rainbow Children's Medicare Limited delivered a strong Q1 FY27 with robust revenue and EBITDA growth, driven by both organic expansion and new acquisitions. The company is aggressively expanding its network into new strategic markets like Mumbai and strengthening its presence in Andhra Pradesh, while maintaining healthy operating margins despite initial ramp-up costs. Management is confident in achieving its long-term growth targets, including doubling revenue in four years and expanding bed capacity to 5,000 beds.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q1 FY27: revenue up 33.1%, net profit up 16.7% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 417 | 398 | 370 | 353 | 445 +7% | 445 +12% | 460 +24% | 470 +33% |
| EBITDA | 147 | 134 | 115 | 104 | 149 +1% | 147 +10% | 145 +26% | 135 +30% |
| Net profit | 79 | 69 | 57 | 54 | 76 −4% | 74 +7% | 78 +37% | 63 +17% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.





